Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
Clinical trial NCT03615924 · TERMINATED
Trial details
- NCT number
- NCT03615924
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-26
- Primary completion
- 2020-08-13
- Enrollment
- 193
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.